✦ LIBER ✦

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy

✍ Scribed by Knopinska-Posluszny, W; Hellmann, A; Gozdzik, J; Hansz, J; Smolewski, P; Robak, T; Osowiecki, M; Walewski, J; Czyz, J; Szydlo, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conventional salvage chemotherapy vs. hi

✍ A. P. Anselmo; G. Meloni; E. Cavalieri; A. Proia; R. Maurizi Enrici; D. Funaro; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 73 KB

Patterns of failure following high dose

✍ A.J. Mundt; Gregory Sibley; Stephanie Williams; Dennis Hallahan; Ralph Weichselb 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 176 KB

High-dose chemotherapy with autologous s

✍ Czyż, J; Hellmann, A; Dziadziuszko, R; Hansz, J; Goździk, J; Hołowiecki, J; Stel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

A Phase I Toxicity and Feasibility Trial

✍ Leisha A. Emens; M. John Kennedy; John H. Fetting; Nancy E. Davidson; Elizabeth 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 150 KB

A randomized trial of chemotherapy with

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB